Anchor Investment Management, LLC Veracyte, Inc. Transaction History

Anchor Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jan 02, 2024	SELL	$21.94 - $42.51 $5,112 - $9,904	-233 Closed	0 $0
Q3 2021 Jan 02, 2024	BUY	$35.62 - $52.97 $8,299 - $12,342	233 New	233 $10.8 Million
Q2 2021 Jan 02, 2024	SELL	$32.94 - $56.62 $4,479 - $7,700	-136 Reduced 36.86%	233 $9.32 Million
Q1 2021 Jan 02, 2024	SELL	$44.47 - $81.38 $88 - $162	-2 Reduced 0.54%	369 $19.8 Million
Q3 2020 Jan 02, 2024	BUY	$26.73 - $35.67 $9,916 - $13,233	371 New	371 $12.1 Million
Q4 2019 Jan 02, 2024	BUY	$20.78 - $29.99 $7,709 - $11,126	371 New	371 $10.4 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anchor Investment Management, LLC with notifications on news.